Rhinomed Limited Company Information

Rhinomed Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Rhinomed Limited
  • Ticker: RNO
  • Exchange: ASX
  • Founded: 2004
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: AU$11.509m
  • Shares Outstanding: 287.72m
  • Website: https://www.rhinomed.global

Location

  • Rhinomed Limited
  • 132 Gwynne Street
  • Level 1
  • Cremorne
  • Victoria
  • 3121
  • Australia


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RNOASX (Australian Securities Exchange)YesOrdinary SharesAUAUDSep 2007
RNOCHIA (Chi-X Australia)YesOrdinary SharesAUAUDSep 2007
RHNM.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDSep 2007

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/02/20 08:03
End of Day Share Price 2024/02/19 00:00
Earnings2023/06/30
Annual Earnings2023/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.